Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 19, Issue 24, 2013, Pages 3872-3882

  Ni, Jia Yan ^a   Liu, Shan Shan ^b   Xu, Lin Feng ^a   Sun, Hong Liang ^a   Chen, Yao Ting ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Meta analysis; Radiofrequency ablation; Transcatheter arterial chemoembolization

Indexed keywords

ARTICLE; CELL HETEROGENEITY; CHEMOEMBOLIZATION; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; SAFETY; TUMOR GROWTH;

EID: 84879569695     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i24.3872     Document Type: Article

References (31)

1. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA, Zheng SS, Sarin S, Hamid SS, Modawi SB, Fleig W, Fedail S, Thomson A, Khan A, Malfertheiner P, Lau G, Carillo FJ, Krabshuis J, Le Mair A. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol 2010; 44: 239-245 [PMID: 20216082 DOI: 10.1097/MCG.0b013e3181d46ef2]
2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236 [PMID: 16250051 DOI: 10.1002/hep.20933]
3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156 [PMID: 11668491 DOI: 10.1002/ijc.1440]
4. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442 [PMID: 12540794 DOI: 10.1053/jhep.2003.50047]
5. El Awady MK, Bader El Din NG, Tabll A, El Hosary Y, Abdel Aziz AO, El Khayat H, Salama M, Abdelhafez TH. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients. World J Gastro-enterol 2013; 19: 290-298 [PMID: 23345953 DOI: 10.3748/wjg. v19.i2.284]
6. Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 1999; 20: 47-53 [PMID: 10407974 DOI: 10.1055/s-1999-14233]
7. Bruix J, Sala M, Llovet JM. Chemoembolization for hepa-tocellular carcinoma. Gastroenterology 2004; 127: S179-S188 [PMID: 15508083 DOI: 10.1053/j.gastro.2004.09.032]
8. Lencioni R. Chemoembolization for hepatocellular carcinoma. Semin Oncol 2012; 39: 503-509 [PMID: 22846867 DOI: 10.1053/j.seminoncol.2012.05.004]
9. Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stiglia-no R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. J Nucl Med 2009; 50: 871-877 [PMID: 19443599 DOI: 10.2967/jnumed.108.060558]
10. Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol 2009; 24: 806-814 [PMID: 19207681 DOI: 10.1111/j.1440-1746.2008.05728.x]
11. Farinati F, Giacomin A, Vanin V, Giannini E, Trevisani F. TACE treatment in hepatocellular carcinoma: what should we do now? J Hepatol 2012; 57: 221-222 [PMID: 22286000 DOI: 10.1016/j.jhep.2011.12.022]
12. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fu-jishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-1209 [PMID: 15690326 DOI: 10.1002/cncr.20892]
13. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328 [PMID: 16495695 DOI: 10.1097/01. sla.0000201480.65519.b8]
14. Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012; 262: 689-700 [PMID: 22157201 DOI: 10.1148/ radiol.11110637]
15. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, Yi CH. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 2008; 299: 1669-1677 [PMID: 18398079 DOI: 10.1001/jama.299.14.1669]
16. Yang W, Chen MH, Wang MQ, Cui M, Gao W, Wu W, Wu JY, Dai Y, Yan K. Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 2009; 39: 231-240 [PMID: 19054154 DOI: 10.1111/j.1872-034X.2008.00451.x]
17. Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol 2012; 81: e189-e193 [PMID: 21353417 DOI: 10.1016/j.ejrad.2011.01.122]
18. Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, To-gashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembo-lization more effective than radiofrequency ablation alone for treatment? Radiology 2009; 252: 905-913 [PMID: 19567647 DOI: 10.1148/radiol.2523081676]
19. Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210-1224 [PMID: 21766289 DOI: 10.1002/bjs.7669]
20. Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010; 116: 5452-5460 [PMID: 20672352 DOI: 10.1002/ cncr.25314]
21. Yang P, Liang M, Zhang Y, Shen B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv Ther 2008; 25: 787-794 [PMID: 18670743 DOI: 10.1007/s12325-008-0079-x]
22. Kang CB, Xu HB, Wang SL, Rui B. Treatment of large hepa-toma by TACE in combination with RFA. Zhonghua Gandan Waike Zazhi 2007; 13: 828-830 [DOI: 10.3760/cma.j.issn.1007-8118.2007.12.011]
23. Shen SQ, Xiang JJ, Xiong CL, Wu SM, Zhu SS. Intraopera-tive radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoemboli-zation for unresectable HCC. Hepatogastroenterology 2005; 52: 1403-1407 [PMID: 16201083 DOI: 10.1074/jbc.273.46.30092]
24. Zhang Z, Wu M, Chen H, Chen D, He J. [Percutaneous ra-diofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma]. Zhonghua Waike Zazhi 2002; 40: 826-829 [PMID: 12487855]
25. Yan S, Xu D, Sun B. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2012; 57: 3026-3031 [PMID: 22585384 DOI: 10.1007/s10620-012-2212-6]
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188 [PMID: 3802833 DOI: 10.1016/ 0197-2456(86)90046-2]
27. Widmann G, Schullian P, Haidu M, Bale R. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardio-vasc Intervent Radiol 2012; 35: 570-580 [PMID: 21671150 DOI: 10.1007/s00270-011-0200-4]
28. Meza-Junco J, Montano-Loza AJ, Liu DM, Sawyer MB, Bain VG, Ma M, Owen R. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how? Cancer Treat Rev 2012; 38: 54-62 [PMID: 21726960 DOI: 10.1016/ j.ctrv.2011.05.002]
29. Zhao M, Wang JP, Pan CC, Li W, Huang ZL, Zhang L, Fang WJ, Jiang Y, Li XS, Wu PH. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement. Eur J Radiol 2012; 81: 2717-2725 [PMID: 22245655 DOI: 10.1016/j.ejrad.2011.10.023]
30. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928 [PMID: 22008217 DOI: 10.1136/bmj.d5928]
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634 [PMID: 9310563 DOI: 10.1136/bmj.315.7109.629]